What AbbVie Manufacturing Does

AbbVie is a pharmaceutical company that manufactures medications at facilities across the United States and internationally. The company produces drugs for conditions including rheumatoid arthritis, hepatitis C, immunology disorders, oncology (cancer), neurology, and women's health. AbbVie operates manufacturing plants that handle different stages of drug production — from creating the active ingredients to packaging finished medications for distribution to pharmacies and hospitals.

The company was spun off from Abbott Laboratories in 2013 and is headquartered in North Chicago, Illinois. Understanding how AbbVie's manufacturing works can help you understand where your medications come from and why certain drugs may be in short supply or subject to recalls.

Key Takeaways

  • AbbVie operates manufacturing facilities in multiple U.S. states and countries, producing both brand-name and generic medications.
  • The company manufactures drugs across several therapeutic areas, with a focus on immunology, oncology, virology, and neurology treatments.
  • AbbVie's main U.S. manufacturing sites are located in Illinois, Puerto Rico, and other states, each specializing in different drug types or production stages.
  • Manufacturing disruptions at AbbVie facilities can affect medication availability, which is why the FDA monitors production and recalls.

AbbVie's Major Manufacturing Locations

AbbVie operates several significant manufacturing facilities. The company's primary U.S. operations include plants in North Chicago, Illinois (headquarters and manufacturing), Abbott Park, Illinois, and facilities in Puerto Rico. The Puerto Rico location is particularly important for AbbVie's production capacity and has historically been a major site for manufacturing active pharmaceutical ingredients and finished medications.

Internationally, AbbVie runs manufacturing operations in countries including Germany, Italy, Japan, Mexico, and the United Kingdom. Each facility is designed to meet regulatory standards in its region and to serve specific markets. The company also contracts with third-party manufacturers to produce certain medications, a practice common across the pharmaceutical industry.

Manufacturing locations are chosen based on proximity to markets, regulatory environment, labor availability, and existing infrastructure. A single medication may be manufactured at multiple sites to may support supply continuity and reduce the risk that a single facility problem disrupts patient access.

What Medications AbbVie Manufactures

AbbVie's product portfolio includes several well-known medications. In immunology, the company manufactures Rinvoq (for rheumatoid arthritis and other inflammatory conditions) and Skyrizi (for plaque psoriasis). In virology, AbbVie produces Mavyret (for hepatitis C). The company also manufactures Kaletra (for HIV), Creon (for pancreatic insufficiency), and Androgel (testosterone replacement).

For oncology, AbbVie produces Venclexta (for certain blood cancers) and Elagolix (for endometriosis). The company also manufactures a range of generic medications through its generic division. The specific medications produced at each facility depend on the equipment, informed, and regulatory certifications available at that location.

AbbVie regularly updates its manufacturing footprint based on demand, regulatory changes, and business strategy. If you take an AbbVie medication, the label or package insert will indicate the manufacturer's location, though the actual production may have occurred at a facility different from the one listed if the company contracts manufacturing out.

How Manufacturing Disruptions Affect Medication Supply

When an AbbVie manufacturing facility experiences problems — such as equipment failure, contamination, quality issues, or natural disasters — it can reduce the supply of medications produced there. The FDA monitors pharmaceutical manufacturing closely and may issue recalls if quality standards are not met. These disruptions can lead to temporary shortages of specific medications at pharmacies.

AbbVie maintains inventory buffers and uses multiple manufacturing sites partly to prevent single-facility problems from cutting off patient access. However, if a major facility goes offline or reduces production significantly, patients and healthcare providers may face delays in obtaining certain medications. The company communicates with healthcare providers and the FDA when supply issues occur.

If you cannot obtain an AbbVie medication due to a shortage, your doctor can sometimes prescribe an alternative medication or a generic equivalent. The FDA maintains a list of drug shortages on its website, which is updated regularly and includes information about which medications are affected and expected timelines for resolution.

Quality Standards and Regulatory Oversight

AbbVie's manufacturing facilities must comply with FDA regulations and international standards such as Good Manufacturing Practice (GMP). These standards govern everything from the cleanliness of production areas to the testing of raw materials and finished products. The FDA conducts unannounced inspections of pharmaceutical manufacturing facilities to verify compliance.

Each batch of medication produced undergoes testing before it is released for distribution. AbbVie maintains detailed records of production, testing, and quality control for every batch. If a problem is discovered — either during production or after a medication reaches the market — the company is required to report it to the FDA and may issue a recall.

Recalls can be voluntary (initiated by AbbVie) or mandated by the FDA. They are classified by severity: Class I recalls involve serious health risks, Class II recalls involve potential health risks, and Class III recalls involve minimal health risk. You can check the FDA's recall database to see if any AbbVie medications you take have been subject to recalls.

Generic and Brand-Name Production

AbbVie manufactures both brand-name medications (sold under specific brand names like Rinvoq or Mavyret) and generic medications (sold by chemical name or under various generic labels). Generic medications contain the same active ingredient as brand-name drugs but are typically less expensive. AbbVie's generic division produces medications across many therapeutic categories.

The manufacturing process for generics is similar to that for brand-name drugs — both must meet the same FDA quality and safety standards. The main difference is that generic manufacturers do not conduct the original research and development, so they can produce medications at lower cost. AbbVie competes in both markets, allowing the company to serve patients at different price points.

When a brand-name medication's patent expires, other manufacturers (including generic divisions of large companies like AbbVie) can produce generic versions. This is why you may see the same medication available under multiple brand names or as a generic — they are chemically identical but produced by different companies or divisions.

How to Find Information About Your AbbVie Medication

If you take a medication manufactured by AbbVie, you can find detailed information on the company's website or on the medication's package insert. The package insert lists the manufacturer's name and location, ingredients, dosage instructions, side effects, and other important information. Your pharmacist can also answer questions about where a medication was manufactured and what to do if you experience problems.

If you want to report a problem with an AbbVie medication — such as an adverse effect, quality issue, or suspected counterfeit product — you can contact AbbVie directly through its website or call the FDA's MedWatch program at 1-888-SAFEFDA. The FDA uses these reports to monitor medication safety and may take action if patterns of problems emerge.

AbbVie also maintains a patient information program that can help uninsured or underinsured patients obtain medications at reduced cost. Information about these programs is available on the company's website or through your healthcare provider.

Frequently Asked Questions

Where is my AbbVie medication manufactured?

The manufacturing location is listed on your medication's package insert or label. AbbVie produces medications at multiple facilities in the U.S. and internationally. If you do not see the location on your package, ask your pharmacist or check the company's website — the specific facility may vary depending on when and where your prescription was filled.

What should I do if there is a recall on my AbbVie medication?

Check the FDA's recall database to understand the reason for the recall and the severity. If your medication is affected, contact your pharmacist or doctor for guidance. Do not stop taking the medication without speaking to your healthcare provider first, as stopping suddenly can be harmful for some conditions. Your pharmacist can tell you whether a replacement is available or if you should wait for new stock.

Are AbbVie generic medications as safe as brand-name versions?

Yes. Generic and brand-name medications must meet the same FDA safety and quality standards. The active ingredient is identical, and both undergo the same testing and manufacturing oversight. The main difference is cost — generics are typically less expensive because the manufacturer did not pay for the original research and development.

How does AbbVie prevent contamination in its manufacturing facilities?

AbbVie follows FDA Good Manufacturing Practice standards, which include strict requirements for facility cleanliness, equipment maintenance, employee training, and testing of raw materials and finished products. The FDA conducts unannounced inspections to verify compliance. Each batch is tested before release, and detailed records are kept for traceability if a problem occurs.

Can I find out which AbbVie facility produced my specific medication?

The package insert lists the manufacturer's location, but it may not identify the exact facility if AbbVie operates multiple plants in the same region. Your pharmacist may be able to provide more specific information based on the lot number on your prescription bottle. AbbVie's customer service line can also help trace a specific batch if you have questions about its origin.